Current status and perspectives on vaccine development against dengue virus infection

J Park, J Kim, YS Jang - Journal of Microbiology, 2022 - Springer
Dengue virus (DENV) consists of four serotypes in the family Flaviviridae and is a causative
agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is …

Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies

S Malik, O Ahsan, H Mumtaz, M Tahir Khan, R Sah… - Vaccines, 2023 - mdpi.com
Background: Nearly half of the world is at risk of developing dengue infection. Dengue virus
is the causative agent behind this public healthcare concern. Millions of dengue cases are …

Dengue virus vaccine development

LE Yauch, S Shresta - Advances in virus research, 2014 - Elsevier
Dengue virus (DENV) is a significant cause of morbidity and mortality in tropical and
subtropical regions, causing hundreds of millions of infections each year. Infections range …

Vaccines for the prevention of dengue: development update

SJ Thomas, TP Endy - Human vaccines, 2011 - Taylor & Francis
The dengue viruses (DENV) are mosquito-borne flaviviruses which cause a spectrum of
clinical disease known as “dengue,” and have emerged and re-emerged as a significant …

[HTML][HTML] Targets and strategies for vaccine development against dengue viruses

WH Wang, AN Urbina, CY Lin, ZS Yang… - Biomedicine & …, 2021 - Elsevier
Dengue virus (DENV) is a global health threat causing about half of the worldwide
population to be at risk of infection, especially the people living in tropical and subtropical …

Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art

J Pintado Silva… - Journal of General …, 2023 - microbiologyresearch.org
Dengue virus (DENV) is the mosquito-borne virus of greatest human health concern. There
are four serotypes of DENV (1-4) that co-circulate in endemic areas. Each serotype of DENV …

Dengue vaccines: challenges, development, current status and prospects

A Ghosh, L Dar - Indian journal of medical microbiology, 2015 - Elsevier
Infection with dengue virus (DENV) is the most rapidly spreading mosquito-borne viral
disease in the world. The clinical spectrum of dengue, caused by any of the four serotypes of …

Current progress in dengue vaccines

SW Wan, CF Lin, S Wang, YH Chen, TM Yeh… - Journal of biomedical …, 2013 - Springer
Dengue is one of the most important emerging vector-borne viral diseases. There are four
serotypes of dengue viruses (DENV), each of which is capable of causing self-limited …

Prospects for a dengue virus vaccine

SS Whitehead, JE Blaney, AP Durbin… - Nature Reviews …, 2007 - nature.com
The number of cases of severe dengue disease continues to grow in endemic areas of
southeast Asia, Central and South America, and other subtropical regions. Children bear the …

Dengue vaccine: priorities and progress

MG Guzman, M Muné, G Kourí - Expert Review of Anti-Infective …, 2004 - Taylor & Francis
Dengue transmission has increased considerably in the past 20 years. Currently, it can only
be reduced by mosquito control; however, the application of vector-control methods are …